Illumina: Illumina & Tempus collaborate to drive future of precision medicine through genomic AI innovation
Illumina Inc. and Tempus AI, Inc., a technology company leading the adoption of AI to advance precision medicine and patient care, announced a collaboration to accelerate clinical adoption of next─generation
Read full article »
Illumina is a California-based biotechnology company that designs and develops products such as sequencing reagents and microarray kits for the life sciences industry.
Read more